Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Niina Ueno, MD, Shikiko Ueno, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Hiro Tatetsu, MD PhD, Shinya Hirata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2015) 126 (23): 2957.

https://doi.org/10.1182/blood.V126.23.2957.2957

Published: 2015

Journal Articles

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Shinya Endo, MD, Hiromichi Yuki, MD PhD, Yoshihiro Komohara, MD PhD, Shikiko Ueno, MD PhD, Nao Nishimura, MD, Niina Ueno, MD, Hiro Tatetsu, MD PhD, Motohiro Takeya, MD PhD, Hiroyuki Hata, MD PhD, Seiji Okada, MD PhD, Daniel G. Tenen, MD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 29.

https://doi.org/10.1182/blood.V124.21.29.29

Published: 2014

Journal Articles

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

Nao Nishimura, MD, Shinya Endo, MD, Niina Ueno, MD, Shikiko Ueno, MD PhD, Hiromichi Yuki, MD PhD, Hiroyuki Hata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 2047.

https://doi.org/10.1182/blood.V124.21.2047.2047

Published: 2014

Journal Articles

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

Hiro Tatetsu, MD PhD, Fei Wang, Chong Gao, MD PhD, Shikiko Ueno, MD PhD, Xi Tian, BS, Myriam Armant, PhD, Alex Federation, Jun Qi, PhD, James E. Bradner, Daniel G. Tenen, MD, Li Chai, MD

Blood (2014) 124 (21): 1566.

https://doi.org/10.1182/blood.V124.21.1566.1566

Published: 2014

Journal Articles

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

Hiro Tatetsu, MD, PhD, Chong Gao, MD, PhD, Shikiko Ueno, MD, PhD, Daniel G Tenen, MD, Li Chai, MD

Blood (2012) 120 (21): 2337.

https://doi.org/10.1182/blood.V120.21.2337.2337

Published: 2012

Journal Articles

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

Hiromichi Yuki, MD, Shikiko Ueno, MD, PhD, Hiroaki Niiro, MD, PhD, Hiro Tatetsu, MD, PhD, Hiroyuki Hata, MD, PhD, Toshiki Watanabe, MD, PhD, Seiji Okada, MD, Ph.D, Koichi Akashi, MD, PhD., Hiroaki Mitsuya, Professor, Yutaka Okuno, MD, PhD

Blood (2011) 118 (21): 2628.

https://doi.org/10.1182/blood.V118.21.2628.2628

Published: 2011

Journal Articles

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Shikiko Ueno, MD, PhD, Jiayun Lu, PhD, He Jie, PhD, Ailing Li, PhD, XiaoXian Zhang, Leslie E Silberstein, MD, Jerome Ritz, MD, Li Chai, MD

Blood (2011) 118 (21): 2428.

https://doi.org/10.1182/blood.V118.21.2428.2428

Published: 2011

NARROW

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only